Terms: = Ovarian epithelial cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53
1009 results:
1. Pre-ciliated tubal epithelial cells are prone to initiation of high-grade serous ovarian carcinoma.
Flesken-Nikitin A; Ralston CQ; Fu DJ; De Micheli AJ; Phuong DJ; Harlan BA; Ashe CS; Armstrong AP; McKellar DW; Ghuwalewala S; Ellenson LH; Schimenti JC; Cosgrove BD; Nikitin AY
Nat Commun; 2024 Oct; 15(1):8641. PubMed ID: 39366996
[TBL] [Abstract] [Full Text] [Related]
2. The chromatin landscape of high-grade serous ovarian cancer metastasis identifies regulatory drivers in post-chemotherapy residual tumour cells.
Croft W; Pounds R; Jeevan D; Singh K; Balega J; Sundar S; Williams A; Ganesan R; Kehoe S; Ott S; Zuo J; Yap J; Moss P
Commun Biol; 2024 Sep; 7(1):1211. PubMed ID: 39341888
[TBL] [Abstract] [Full Text] [Related]
3. High-throughput drug screening identifies novel therapeutics for Low Grade Serous ovarian Carcinoma.
Pishas KI; Cowley KJ; Llaurado-Fernandez M; Kim H; Luu J; Vary R; Bowden NA; Campbell IG; Carey MS; Simpson KJ; Cheasley D
Sci Data; 2024 Sep; 11(1):1024. PubMed ID: 39300112
[TBL] [Abstract] [Full Text] [Related]
4. The synergistic mechanisms of propofol with cisplatin or doxorubicin in human ovarian cancer cells.
Sue SH; Tseng WC; Wu ZS; Huang SM; Chen JL; Wu ZF; Lai HC
J Ovarian Res; 2024 Sep; 17(1):187. PubMed ID: 39272193
[TBL] [Abstract] [Full Text] [Related]
5. Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin.
Nishijima A; Oda K; Hasegawa K; Koso T; Asada K; Ikeda Y; Taguchi A; Maeda D; Nagae G; Tsuji S; Tatsuno K; Uehara Y; Kurosaki A; Sato S; Tanikawa M; Sone K; Mori M; Ikemura M; Fujiwara K; Ushiku T; Osuga Y; Aburatani H
Sci Rep; 2024 Aug; 14(1):18797. PubMed ID: 39138354
[TBL] [Abstract] [Full Text] [Related]
6. Improving histotyping precision: The impact of immunohistochemical algorithms on epithelial ovarian cancer classification.
Zelisse HS; Dijk F; van Gent MDJM; Hooijer GKJ; Mom CH; van de Vijver MJ; Snijders MLH
Hum Pathol; 2024 Sep; 151():105631. PubMed ID: 39084566
[TBL] [Abstract] [Full Text] [Related]
7. Mesonephric-type adenocarcinomas of the ovary: prevalence, diagnostic reproducibility, outcome, and value of PAX2.
Köbel M; Kang EY; Lee S; Ogilvie T; Terzic T; Wang L; Wiebe NJ; Al-Shamma Z; Cook LS; Nelson GS; Stewart CJ; von Deimling A; Kommoss FK; Lee CH
J Pathol Clin Res; 2024 Jul; 10(4):e12389. PubMed ID: 38970797
[TBL] [Abstract] [Full Text] [Related]
8. Estimating pathological prognostic factors in epithelial ovarian cancers using apparent diffusion coefficients of functional tumor volume.
Zhang C; Ma L; Zhao Y; Zhang Z; Zhang Q; Li X; Qin J; Ren Y; Hu Z; Zhao Q; Shen W; Cheng Y
Eur J Radiol; 2024 Jul; 176():111514. PubMed ID: 38776804
[TBL] [Abstract] [Full Text] [Related]
9. Does serous tubal intraepithelial carcinoma (STIC) metastasize? The clonal relationship between STIC and subsequent high-grade serous carcinoma in BRCA1/2 mutation carriers several years after risk-reducing salpingo-oophorectomy.
van den Berg CB; Dasgupta S; Ewing-Graham PC; Bart J; Bulten J; Gaarenstroom KN; de Hullu JA; Mom CH; Mourits MJE; Steenbeek MP; van Marion R; van Beekhuizen HJ
Gynecol Oncol; 2024 Aug; 187():113-119. PubMed ID: 38759517
[TBL] [Abstract] [Full Text] [Related]
10. Cell Cycle-Related Centromere Protein F Deficiency Suppresses ovarian cancer Cell Growth by Inducing Ferroptosis.
Liu X; Guo L; Suo Y; Tang X; Zhu T; Zhao T; Zhang W; Zhang P
Gynecol Obstet Invest; 2024; 89(5):424-436. PubMed ID: 38723616
[TBL] [Abstract] [Full Text] [Related]
11. Pan-cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies.
Miller CD; Lozada JR; Zorko NA; Elliott A; Makovec A; Radovich M; Heath EI; Agarwal N; Mckay RR; Garje R; Bastos BR; Hoon DSB; Orme JJ; Sartor O; VanderWalde A; Nabhan C; Sledge G; Shenderov E; Dehm SM; Lou E; Miller JS; Hwang JH; Antonarakis ES
Cancer Res Commun; 2024 May; 4(5):1369-1379. PubMed ID: 38709075
[TBL] [Abstract] [Full Text] [Related]
12. Static magnetic field reduces cisplatin resistance via increasing apoptosis pathways and genotoxicity in cancer cell lines.
Zafari J; Rastegar-Pouyani N; Javani Jouni F; Najjar N; Azarshin SZ; Jafarzadeh E; Abdolmaleki P; Hoseini Shirazi F
Sci Rep; 2024 Mar; 14(1):5792. PubMed ID: 38461218
[TBL] [Abstract] [Full Text] [Related]
13. STEAP3 Affects ovarian cancer Progression by Regulating Ferroptosis through the p53/SLC7A11 Pathway.
Han Y; Fu L; Kong Y; Jiang C; Huang L; Zhang H
Mediators Inflamm; 2024; 2024():4048527. PubMed ID: 38440354
[TBL] [Abstract] [Full Text] [Related]
14. HER2-low and Overexpression in Mucinous ovarian cancer: Analysis of ASCO/CAP and ToGA Immunohistochemical Scoring.
Han R; Madariaga A; Gonzalez-Ochoa E; Smith AC; Wang L; Lheureux S; Rouzbahman M
Int J Gynecol Pathol; 2024 May; 43(3):275-283. PubMed ID: 38436360
[TBL] [Abstract] [Full Text] [Related]
15. Immunohistochemical and molecular pattern of p53 in epithelial ovarian cancers negative for germline BRCA1/2 variants.
Ronchi S; Facchi S; Di Lauro E; Libera L; Carnevali IW; Zefiro F; Alexandrova E; Rizzo F; Sessa F; Tibiletti MG
Pathol Res Pract; 2024 Mar; 255():155183. PubMed ID: 38364651
[TBL] [Abstract] [Full Text] [Related]
16. CD47-a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features.
Luo X; Mo J; Zhang M; Huang W; Bao Y; Zou R; Yao L; Yuan L
World J Surg Oncol; 2024 Feb; 22(1):44. PubMed ID: 38317230
[TBL] [Abstract] [Full Text] [Related]
17. BRCA1, BRCA2, and tp53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer.
Richau CS; Scherer NM; Matta BP; de Armas EM; de Barros Moreira FC; Bergmann A; Pereira Chaves CB; Boroni M; Dos Santos ACE; Moreira MAM
Cancer Med; 2024 Feb; 13(3):e6729. PubMed ID: 38308422
[TBL] [Abstract] [Full Text] [Related]
18. Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions.
Chien YW; Wang Y; Huang P; Lawson BC; Kolin DL; Chui MH; Vang R; Numan TA; Soong TR; Wang BG; Smith SA; Chen CL; Stone R; Douville C; Wang TL; Shih IM
Am J Surg Pathol; 2024 Apr; 48(4):475-486. PubMed ID: 38298022
[TBL] [Abstract] [Full Text] [Related]
19. Human Fallopian Tube-Derived Organoids with tp53 and RAD51D Mutations Recapitulate an Early Stage High-Grade Serous ovarian cancer Phenotype In Vitro.
Dai Y; Xu J; Gong X; Wei J; Gao Y; Chai R; Lu C; Zhao B; Kang Y
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255960
[TBL] [Abstract] [Full Text] [Related]
20. FGL2 promotes tumour growth and attenuates infiltration of activated immune cells in melanoma and ovarian cancer models.
Galpin KJC; Rodriguez GM; Maranda V; Cook DP; Macdonald E; Murshed H; Zhao S; McCloskey CW; Chruscinski A; Levy GA; Ardolino M; Vanderhyden BC
Sci Rep; 2024 Jan; 14(1):787. PubMed ID: 38191799
[TBL] [Abstract] [Full Text] [Related]
[Next]
